European Journal of Radiology
Volume 42, Issue 1 , Pages 2-9 , April 2002

Imaging and management of nonpalpable lesions of the breast

  • A.A. Tardivon

      Affiliations

    • Department of Radiology, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4211-4825; fax: +33-1-4211-5279
    • ,
  • J.M. Guinebretière

      Affiliations

    • Department of Pathology C, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    • ,
  • C. Dromain

      Affiliations

    • Department of Radiology, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    • ,
  • D. Vanel

      Affiliations

    • Department of Radiology, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France

Received 24 January 2002 ,Revised 25 January 2002 ,Accepted 28 January 2002.

References 

  1. Bassett LW, Farria DM, Bansal S, Farquhar MA, Wilcox PA, Feig SA. Reasons for failure of a mammography unit at clinical image review in the American College of Radiology Mammography Accreditation Program. Radiology. 2000;215:698–702
  2. Heywang-Köbrunner SH, Schreer I, Dershaw DD. Mammography. In:  Heywang-Köbrunner SH,  Schreer I,  Dershaw DD editor. Diagnostic breast imaging. Stuttgart, New York: Thieme; 1997;p. 11–80
  3. Tabar L, Dean PB. Method for systemating viewing of mammograms. In:  Tabar L,  Dean PB editor. Teaching atlas of mammography. Stuttgart, New York: Thieme; 2001;p. 5–14
  4. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 2nd ed. Reston, VA: American College of Radiology, 1995.
  5. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3184 consecutive cases. Radiology. 1991;179:463–468
  6. Varas X, Lebirgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology. 1992;184:409–414
  7. Vizcaino I, Gadea L, Andreo L, Salas D, Ruiz-Perales F, Cuevas D, Herranz C, Bueno F, and the Screening Program Working Group. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001;219:475–83.
  8. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast imaging reporting and data system: positive value of mammographic features and final assessment categories. Am J Roentgenol. 1998;171:35–40
  9. Sickles EA. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology. 1999;213:11–14
  10. Caplan LS, Blackman D, Nadel M, Monticciolo DL. Coding mammograms using the classification ‘probably benign finding-short interval follow-up suggested. Am J Roentgenol. 1999;172:339–342
  11. Berg WA, Campassi C, Langenberg P, Sexton MJ. Breast imaging reporting and data system: inter- and intraobserver variability in feature analysis and final assessment. Am J Roentgenol. 2000;174:1769–1777
  12. Madjar H, Rickard M, Jelins J, Otto R. IBUS guidelines for the ultrasonic examination of the breast. IBUS International Faculty. International Breast Ultrasound School. Eur J Ultrasound. 1999;9:99–102
  13. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995;196:123–134
  14. Skaane P, Engedal K. Analysis of sonographic features in the differentiation of fibroadenoma and invasive ductal carcinoma. Am J Roentgenol. 1998;170:109–114
  15. Lamb PM, Perry NM, Vinicombe SJ, Wells CA. Correlation between characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol. 2000;55:44–70
  16. Rahbar G, Sie AC, Hansen GC, Prince JS, Melany ML, Reynolds HE, et al. Benign versus malignant solid breast masses: US differentiation. Radiology. 1999;213:889–894
  17. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound. Cancer. 1995;76:626–630
  18. Mesurolle B, Mignon F, Ariche-Cohen M, Tardivon A, Goumot PA. High-resolution ultrasound appearance of small breast lesions. The radiologist. 2001;8:291–301
  19. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology. 1998;207:191–199
  20. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221:641–649
  21. Heywang-Köbrunner SH, Heinig A, Pickuth D, Alberich T, Spielmann RP. Interventional MRI of the breast: lesion localisation and biopsy. Eur Radiol. 2000;10:36–45
  22. Westerhof JP, Fischer U, Moritz JD, Oestmann JW. MR imaging of mammographically detected clustered microcalcifications: is there any value?. Radiology. 1998;207:675–681
  23. Greenstein Orel S. MR imaging of the breast. Radiol Clin North Am. 2000;38:899–913
  24. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30
  25. Kuhl CK, Mielcareck P, Klaschick S, Leutner C, Wardelmann E, Gieseke J. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology. 1999;211:101–110
  26. Kuhl CK. MRI of breast tumors. Eur Radiol. 2000;10:46–58
  27. Gribbestad I, Nilsen G, Fjone HE, Kvinnsland S, haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium enhanced—MR mammography. J Magn Reson Imaging. 1994;4:477–480
  28. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology. 2001;219:484–494
  29. Boetes C, Strijk SP, Barentsz JO, Holland R, Mus RDM, Van der Sluis R, et al. False-negative MR imaging of malignant breast tumors. Eur Radiol. 1997;7:1231–1234
  30. Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles E, et al. Dynamic high-spatial-resolution MR imaging of suspicious lesions: diagnostic criteria and interobserver variability. Am J Roentgenol. 2000;175:35–43
  31. Azavedo E, Bone B. Imaging breast with silicone implants. Eur Radiol. 1999;9:349–355
  32. Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology. 2000;215:267–279
  33. Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. Mag Reson Im. 2000;18:765–776
  34. Gilles R, Guinebretière JM, Shapeero L, Lesnik A, Contesso G, Sarrazin D, et al. Contrast-enhanced subtraction MRI for assessment of breast cancer recurrences: preliminary results on 26 patients. Radiology. 1993;188:473–478
  35. Dao TH, Rahmouni A, Servois V, Nguyen Tan T. MR imaging of the breast in the follow-up evaluation of conservative nonoperatively treated breast cancer. Magn Reson Imaging Clin N Am. 1994;2:605–622
  36. Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology. 1997;205:437–440
  37. Schorn C, Fischer U, Luftner-Nagel S, Westerhof JP, Grabbe E. MRI of the breast in patients with metastatic disease of unknown primary. Eur Radiol. 1999;9:470–473
  38. Boetes C, Mus RDM, Holland R, Barentsz JO, Strijk SP, Wobbes T, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743–747
  39. Rodenko GN, Harms SE, Pruneda JM, Farell RS, Evans WP, Copit DS, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol. 1996;167:1416–1419
  40. Essermann L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110–119
  41. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–888
  42. Orel SG, Reynolds C, Schnall MD, Solin LJ, Fraker DL, Sullivan DC. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology. 1997;205:429–436
  43. Soderstrom CE, Harms SE, Farrel RS, Pruneda JM, Flaming DP. Detection with MR imaging of residual tumor in the breast soon after surgery. Am J Roentgenol. 1997;168:485–488
  44. Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. Am J Roentgenol. 2000;175:1577–1584
  45. Gilles R, Guinebretière JM, Toussaint C, Spielman M, Rietjens M, Petit JY, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology. 1994;191:633–638
  46. Rieber A, Zeitler H, Rosenthal H, Gorich J, Kreienberg R, Brambs HJ, et al. MRI of the breast cancer: influence of chemotherapy on sensitivity. Br J Radiol. 1997;70:452–458
  47. Woo IJ, Orel SG, Schnall MD, Desiderio LM, Czerniecki BJ, Tomaszewski JE. MR imaging of the controlateral breast in patients with newly diagnosed breast cancer. Radiology. 2000;217(P):526
  48. Brown J, Smith RC, Lee CH. Incidental enhancing lesions found on MR imaging of the breast. Am J Roentgenol. 2001;176:1249–1254
  49. Kuhl C, Seibert C, Kneft B, Gieseke J. Focal and diffuse contrast enhancement in healthy volunteers. Radiology. 1994;193:121
  50. Fischer U, Vosshenrich R, Döler W, Hamadeh A, Oestmann JW, Grabbe E. MR imaging-guided breast intervention: experience with 2 systems. Radiology. 1995;195:533–538
  51. Döler W, Fischer U, Metzger I, Harder D, Grabbe E. Stereotaxic add-on device for MR-guided biopsy of breast lesions. Radiology. 1996;200:863–864
  52. Heywang-Köbrunner SH, Heinig A, Schamloeffel U, Viehweg P, Smolny T, Buchmann J, et al. MR-guided percutaneous and incisional biopsy of breast lesions. Eur Radiol. 1999;9:1656–1665
  53. Heywang-Köbrunner SH, Heinig A, Pickuth D, Alberich T, Spielmann RP. Interventional MRI of the breast: lesion localisation and biopsy. Eur Radiol. 2000;10:36–45
  54. Liberman L, LaTrenta LR, Dershaw DD. Impact of core biopsy on the surgical management of impalpable breast cancer. Am J Roentgenol. 1997;169:1464–1465
  55. Smith DN, Christian R, Meyer JE. Large-core needle biopsy of nonpalpable breast cancers: the impact on subsequent surgical excision. Arch Surg. 1997;132:256–259
  56. Liberman L, Fahs MC, Dershaw DD, Abramson AF, Morris EA, Cohen MA, et al. Impact of stereotaxic core biopsy on cost of diagnosis. Radiology. 1995;195:633–637
  57. Lee CH, Egglin TIK, Philpotts LE, Maineiro MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology. 1997;202:849–854
  58. Liberman L. Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. Am J Roentgenol. 2000;174:1191–1199
  59. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. Ultrasound-guided core breast biopsy: utility and cost-effectiveness. Radiology. 1998;208:717–723
  60. Gisvold JJ, Goellner JR, Grant CS, Donohue JH, Karsell PR, Coffey SL, et al. Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. Am J Roentgenol. 1994;162:815–820
  61. Liberman L, Evans WP, Dershaw DD, Hann LE, Deutch BM, Abramson AF, et al. Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology. 1994;190:223–225
  62. Mainiero MB, Philpotts LE, Lee CH, Lange RC, Carter D, Tocino I. Stereotaxic core needle biopsy of breast microcalcifications: correlation of target accuracy and diagnosis with lesion size. Radiology. 1996;198:665–669
  63. Burbank F, Parker SH, Fogarty TJ. Stereoatactic breast biopsy: improved tissue harvesting with the mammotome. Am Surg. 1996;62:738–744
  64. Reynolds HE, Poon CM, Goulet RJ, Lazaridis CL. Biopsy of breast microcalcifications using a 11-gauge directional vacuum-assisted device. Am J Roentgenol. 1998;171:611–613
  65. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotacxic core biopsy of breast lesions: an indication for surgical biopsy. Am J Roentgenol. 1995;164:1111–1113
  66. Jackman RJ, Burbank F, Parker SH, Evans PE, Lechner MC, Richardson TR, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485–488
  67. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with a directional, vacuum-assisted biopsy instrument. Radiology. 1997;202:843–847
  68. Brem RF, Behrndt VS, Sanow L, Gatewood OMB. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically directional vacuum-assisted biopsy. Am J Roentgenol. 1999;172:1405–1407
  69. Reynolds HE. Core needle biopsy of challenging benign breast conditions: a comprehensive literature review. Am J Roentgenol. 2000;174:1245–1250
  70. Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzani FA, Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999;212:189–194
  71. Lee CH, Philpotts LE, Horvath LJ, Tocino I. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. Radiology. 1999;212:189–194
  72. Berlin L. Tracking for breast cancer (commentary). Am J Roentgenol. 1998;170:93–95

PII: S0720-048X(02)00038-4

European Journal of Radiology
Volume 42, Issue 1 , Pages 2-9 , April 2002

Article Tools